Silver Book Fact

In the U.S., new cancer drugs have increased life expectancy at birth by 10.7%.

The Expanding Pharmaceutical Arsenal in the War on Cancer. Working Paper No. 10328 Web site. http://www.nber.org/papers/w10328. Published Feb. 2004

Reference

Title
The Expanding Pharmaceutical Arsenal in the War on Cancer
Publication
Working Paper No. 10328
Publisher
National Bureau of Economic Research
Publication Date
Published Feb. 2004
Authors
Lichtenberg F
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Reductions in mortality for lung, female breast, prostate, and colorectal cancers accounted for 60 to 80 percent of the total decrease in all cancer deaths since the early 1990s.  
  • A 10 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $4.4 trillion to current and future generations.  
  • An experimental drug has been found to extend the lives of kidney patients by about 3.5 months–from 7 to just under 11. It has also been shown to delay…  
  • New Drug Increases Brain Cancer Survival Rate: Temozolomide is the first new drug in over 30 years to treat glioblastoma, a severe form of brain cancer  
  • Since 1991 the cancer death rate has fallen by 20 percent.